chr16-20348652-A-C

Variant names:

• chr16-20348652-A-C
• rs28934583
• NM_003361.4:c.649T>G

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1 PM2 PM5 PP2 PP3_Strong PP5

The NM_003361.4(UMOD):​c.649T>G​(p.Cys217Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C217R) has been classified as Pathogenic.

• Frequency: Genomes: not found (cov: 33)
• Consequence: UMOD NM_003361.4 missense
• Clinical Significance: Pathogenic no assertion criteria provided P:1
• Conservation: PhyloP100: 9.01
• Publications: 7 publications found

Genes affected

UMOD (HGNC:12559): (uromodulin) The protein encoded by this gene is the most abundant protein in mammalian urine under physiological conditions. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. This protein may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of this protein in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the renal disorders medullary cystic kidney disease-2 (MCKD2), glomerulocystic kidney disease with hyperuricemia and isosthenuria (GCKDHI), and familial juvenile hyperuricemic nephropathy (FJHN). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2013]

UMOD Gene-Disease associations (from GenCC):

• autosomal dominant medullary cystic kidney disease with or without hyperuricemia

  Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
• glomerulocystic kidney disease with hyperuricemia and isosthenuria

  Inheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
• familial juvenile hyperuricemic nephropathy type 1

  Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
• autosomal dominant medullary cystic kidney disease with hyperuricemia

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

ACMG classification

Our verdict: Pathogenic. The variant received 12 ACMG points.

• PM1: In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 4 uncertain in NM_003361.4
• PM2: Very rare variant in population databases, with high coverage
• PM5: Other missense variant is known to change same aminoacid residue: Variant chr16-20348652-A-G is described in CliVar as Pathogenic. Clinvar id is 12256.Status of the report is no_assertion_criteria_provided, 0 stars.
• PP2: Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 69 curated pathogenic missense variants (we use a threshold of 10). The gene has 14 curated benign missense variants. Gene score misZ: 0.99836 (below the threshold of 3.09). Trascript score misZ: 0.48416 (below the threshold of 3.09). GenCC associations: The gene is linked to autosomal dominant medullary cystic kidney disease with or without hyperuricemia, familial juvenile hyperuricemic nephropathy type 1, glomerulocystic kidney disease with hyperuricemia and isosthenuria, autosomal dominant medullary cystic kidney disease with hyperuricemia.
• PP3: MetaRNN computational evidence supports a deleterious effect, 0.99
• PP5: Variant 16-20348652-A-C is Pathogenic according to our data. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-20348652-A-C is described in CliVar as Pathogenic. Clinvar id is 39418.Status of the report is no_assertion_criteria_provided, 0 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
UMOD	NM_003361.4	c.649T>G	p.Cys217Gly	missense_variant	Exon 3 of 11	ENST00000396138.9	NP_003352.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
UMOD	ENST00000396138.9	c.649T>G	p.Cys217Gly	missense_variant	Exon 3 of 11	5	NM_003361.4	ENSP00000379442.5
UMOD	ENST00000396134.6	c.748T>G	p.Cys250Gly	missense_variant	Exon 4 of 12	2		ENSP00000379438.2
UMOD	ENST00000570689.5	c.649T>G	p.Cys217Gly	missense_variant	Exon 3 of 11	5		ENSP00000460548.1
UMOD	ENST00000573567.5	c.*234T>G		downstream_gene_variant		5		ENSP00000460374.1

Frequencies

GnomAD3 genomes Cov.: 33

GnomAD4 exome Cov.: 35

GnomAD4 genome Cov.: 33

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:1

Revision: no assertion criteria provided

Submissions by phenotype

Familial juvenile hyperuricemic nephropathy type 1 Pathogenic:1

Jan 06, 2012

OMIM

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Pathogenic	0.88
BayesDel_addAF	Pathogenic	0.57	D
BayesDel_noAF	Pathogenic	0.58
CADD	Pathogenic	28
DANN	Uncertain	0.98
Eigen	Pathogenic	0.85
Eigen_PC	Pathogenic	0.75
FATHMM_MKL	Uncertain	0.96	D
LIST_S2	Benign	0.84	T;T;T;.
M_CAP	Pathogenic	0.89	D
MetaRNN	Pathogenic	0.99	D;D;D;D
MetaSVM	Pathogenic	1.0	D
MutationAssessor	Pathogenic	3.8	.;.;H;H
PhyloP100		9.0
PrimateAI	Uncertain	0.75	T
PROVEAN	Pathogenic	-8.2	D;.;D;.
REVEL	Pathogenic	0.99
Sift	Pathogenic	0.0	D;.;D;.
Sift4G	Uncertain	0.0050	D;D;D;D
Polyphen		1.0	.;.;D;D
Vest4		0.80
MutPred		0.94		.;.;Gain of disorder (P = 0.0239);Gain of disorder (P = 0.0239);
MVP		0.92
MPC		2.1
ClinPred		1.0	D
GERP RS		4.6
Varity_R		0.94
gMVP		1.0
Mutation Taster		=0/100	disease causing (ClinVar)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs28934583; hg19: chr16-20359974;